Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

AIDS vaccine development and challenge viruses: getting real.

Vlasak J, Ruprecht RM.

AIDS. 2006 Nov 14;20(17):2135-40. No abstract available.

PMID:
17086052
2.

Progress towards a vaccine to prevent sexual transmission of HIV.

Miller CJ, McGhee JR.

Nat Med. 1996 Jul;2(7):751-2. No abstract available.

PMID:
8673919
3.

Transmission, acute HIV-1 infection and the quest for strategies to prevent infection.

Pope M, Haase AT.

Nat Med. 2003 Jul;9(7):847-52. Review.

PMID:
12835704
4.

AIDS vaccine development in primate models.

Almond NM, Heeney JL.

AIDS. 1998;12 Suppl A:S133-40. Review. No abstract available.

PMID:
9632994
5.

Mucosal immunity, HIV transmission, and AIDS.

Miller CJ, McGhee JR, Gardner MB.

Lab Invest. 1993 Feb;68(2):129-45. Review. No abstract available.

PMID:
8441249
6.

Primate models of AIDS vaccine development.

Lamb-Wharton RJ, Joag SV, Stephens EB, Narayan O.

AIDS. 1997;11 Suppl A:S121-6. Review. No abstract available.

PMID:
9451975
7.

Prospects for live attenuated HIV.

Desrosiers RC.

Nat Med. 1998 Sep;4(9):982. No abstract available.

PMID:
9734368
8.

Progress and obstacles in the development of an AIDS vaccine.

Letvin NL.

Nat Rev Immunol. 2006 Dec;6(12):930-9. Review.

PMID:
17124514
9.

AIDS vaccine: new ideas from old approaches.

Beale AJ.

J R Soc Med. 2003 Jul;96(7):347-8. Review. No abstract available.

10.

Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.

Barnett SW, Srivastava IK, Kan E, Zhou F, Goodsell A, Cristillo AD, Ferrai MG, Weiss DE, Letvin NL, Montefiori D, Pal R, Vajdy M.

AIDS. 2008 Jan 30;22(3):339-48. doi: 10.1097/QAD.0b013e3282f3ca57.

PMID:
18195560
11.

HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.

Cohen J.

Science. 2004 Jun 4;304(5676):1437. No abstract available.

PMID:
15178780
12.

Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques.

Yamamoto H, Kawada M, Tsukamoto T, Takeda A, Igarashi H, Miyazawa M, Naruse T, Yasunami M, Kimura A, Matano T.

J Gen Virol. 2007 Feb;88(Pt 2):652-9.

PMID:
17251584
13.
14.

Search for AIDS vaccine advances.

[No authors listed]

Hum Vaccin Immunother. 2012 Feb;8(2):151. No abstract available.

PMID:
22745942
15.

Cold shower for AIDS vaccines.

[No authors listed]

Nat Med. 2007 Dec;13(12):1389-90. No abstract available.

PMID:
18064013
16.

A new era in HIV vaccine development.

Lau CY, Velasco PP, Johnston MI.

Expert Rev Anti Infect Ther. 2007 Apr;5(2):205-15. Review.

PMID:
17402836
17.

Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccines.

McBurney SP, Ross TM.

Curr Pharm Des. 2007;13(19):1957-64. Review.

PMID:
17627529
18.

Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.

Belyakov IM, Ahlers JD.

Trends Immunol. 2008 Nov;29(11):574-85. doi: 10.1016/j.it.2008.07.010. Review.

PMID:
18838298
19.

Fc receptor but not complement binding is important in antibody protection against HIV.

Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR.

Nature. 2007 Sep 6;449(7158):101-4.

PMID:
17805298
20.

HIV-1/AIDS vaccine development: are we in the darkness.

Qiu C, Xu JQ.

Chin Med J (Engl). 2008 May 20;121(10):939-45. Review. No abstract available.

PMID:
18706210

Supplemental Content

Support Center